Business Description
Adicet Bio is a Boston-based biotech company focused on developing next-generation cell therapies for patients with autoimmune diseases and cancer. Its leading program uses donor-derived immune cells engineered to seek out and attack a specific protein found on harmful cells driving autoimmune conditions. The company is also advancing a second therapy aimed at a target commonly found in prostate cancer. Founded in 2014, Adicet Bio is currently running clinical trials to test the safety and effectiveness of these treatments.
